Dyne: Accelerated Approval Of DYNE-101 Might Be Possible With Surrogate Biomarker
Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.
Dyne Therapeutics to Present at Stifel 2025 Virtual CNS Forum
A live webcast will be available in the Investors & Media section of Dyne’s website at https://investors.dyne-tx.com/news-and-events/events-and-presentations and a replay will be accessible for 90 ...
Hosted on MSN26d
Dyne Therapeutics, Inc. (DYN): Among the Best Rebound Stocks to Invest In Now
In this article, we are going to take a look at where Dyne Therapeutics, Inc. (NASDAQ:DYN) stands against the other rebound stocks. The United States economy is in a constant state of flux.
Yahoo Finance15d
Is Dyne Therapeutics (NASDAQ:DYN) In A Good Position To Deliver On Growth Plans?
When Might Dyne Therapeutics Run Out Of Money? A company's cash runway is calculated by dividing its cash hoard by its cash burn. When Dyne Therapeutics last reported its December 2024 balance ...
Nasdaq28d
Dyne Therapeutics to Present Key Data from DELIVER and ACHIEVE Clinical Trials at 2025 MDA Conference
Dyne Therapeutics, Inc. announced that it will ... and 119 decrease their positions in their most recent quarter. . (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on ...
Dyne Therapeutics (NASDAQ:DYN) Stock Price Down 6.4% After Analyst Downgrade
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report)’s share price was down 6.4% during mid-day trading on Monday after Piper Sandler lowered their price target on the stock from $53.00 to $48.00.
Yahoo Finance23d
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering
The Nasdaq closing bell ceremony will be broadcast live starting at 3:50 p.m. Eastern Time from the Nasdaq MarketSite Tower in New York City, New York. To view the broadcast, please visit ...
Nasdaq18d
First Week of April 17th Options Trading For Dyne Therapeutics (DYN)
Investors in Dyne Therapeutics Inc (Symbol: DYN) saw new options begin trading this week, for the April 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...
Morningstar28d
Dyne Therapeutics Announces Upcoming Presentations at the 2025 MDA Clinical & Scientific Conference
Feb. 14, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing life-transforming therapeutics for people living with ...